Attached files

file filename
8-K - ZYGO CORPc66722_8-k.htm

Exhibit 99.1

(ZYGO LOGO)
News Release

For Further Information Call:
John P. Jordan
Chief Financial Officer
Voice: 860-704-3955
inquire@zygo.com

ZYGO REPORTS RECORD EPS for FISCAL 2011,
Q4 REVENUES UP 50%

MIDDLEFIELD, CT, August 18, 2011 – Zygo Corporation (NASDAQ: ZIGO) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2011 and points out the following highlights in its results:

 

 

 

 

Record earnings achieved for fiscal 2011 of $1.05 per diluted share.

 

Total year bookings of $167.2 million increased 55% over fiscal 2010 bookings of $108.1 million. Fourth quarter bookings increased 50% over the prior year quarter.

 

Revenues increased for the fifth consecutive quarter, reaching $150.1 million for fiscal 2011 – a 48% increase year over year.

 

Q4 continued quarter over quarter earnings growth with net earnings of $6.1 million or $0.33 diluted EPS.

 

Gross margin increased to more than 48% for Q4 - the highest gross margin in 10 years and the fourth consecutive quarter of gross margin and operating margin increases.

 

Operating margin for Q4 reached 16%, the highest operating margin for a quarter in 10 years.

 

Large orders during the quarter included a follow-on order for over $3 million for laser fusion amplifiers and an order from a major medical device company of over $2 million for high precision lens assemblies.

For the fourth quarter of fiscal 2011, revenues of $42.7 million increased 50% from revenues of $28.5 million in the comparable prior year period and 6% from third quarter fiscal 2011 revenues of $40.2 million, reflecting strong demand for both metrology and optics products.

Net earnings of $6.1 million, or $0.33 per diluted share, for the fourth quarter of fiscal 2011 increased by 49% over net earnings of $4.1 million, or $0.23 per diluted share, in the fourth quarter of fiscal 2010. Prior year fourth quarter non-GAAP net earnings from continuing operations, which excludes one-time charges of $0.6 million, were $0.26 per diluted share.

Full year fiscal 2011 net revenues were $150.1 million, a 48% increase over fiscal 2010 revenues of $101.3 million.

1


Fiscal 2011 net earnings were $19.1 million, or $1.05 per diluted share, compared with a net loss of $6.3 million ($3.6 million net loss from continuing operations), or $0.37 net loss per diluted share ($0.21 net loss per diluted share from continuing operations) for fiscal 2010. Results for fiscal 2011 included a gain on acquisition, net of tax, of $0.11 per diluted share. Non-GAAP fiscal 2010 earnings were $2 million or $0.11 per diluted share from continuing operations after adjusting for one-time items. (Refer to “Reconciliation of Reported Results to Non-GAAP Results” included in this Press Release for detail of the one-time items.)

Gross bookings for the fourth quarter of fiscal 2011 were $44.2 million, an increase of 50% over bookings of $29.5 million in the fourth quarter of fiscal 2010 and 6% greater than third quarter fiscal 2011 bookings of $41.7 million. Bookings for the Metrology Solutions Division were 61% of the total; Optical Systems Division bookings were 39%. Backlog rose to $62.0 million at June 30, 2011, compared with $60.5 million at March 31, 2011 and $44.9 million at June 30, 2010.

Commenting on the fourth quarter results, John P. Jordan, Vice President and Chief Financial Officer of Zygo Corporation, said, “Gross margin of nearly 49% and operating margin of 16% in the fourth quarter represent the fourth consecutive quarter of gross margin and operating margin increases and the highest margin levels in 10 years. We also implemented foreign tax reduction measures that reduced fourth quarter and fiscal year income tax expense by $0.03 per diluted share. Our cash and marketable securities position increased to over $61.0 million as a result of the excellent operating performance combined with disciplined management of accounts receivable and inventory, despite the significant growth in revenues.”

Dr. Chris Koliopoulos, President and Chief Executive Officer of Zygo Corporation, commented, “We are very pleased with the fourth quarter results, culminating in a record fiscal year. Over the fiscal year, our revenues, bookings and operating income showed continued quarter over quarter growth, and total year revenues were the highest in 3 years. Our strong bookings continued the positive book-to-bill ratio trend, resulting from our continued product and market diversification and the strength in our markets, and we ended the fiscal year with a growing backlog year over year. Operationally, Zygo continues to improve on its fundamentals, providing further shareholder value with the growth in cash, tangible net worth and return on assets. The combination of expanding demand for metrology and optical test equipment and broad demand for precision optics products, together with the operational initiatives that improved both metrology and optics margins, have enabled the strong performance that has produced record earnings and historically strong margins during this fiscal year. Although it has been reported that certain markets are beginning to reflect cyclical weakness, our strength through innovative product offerings and market diversity appear to be contributing to the uniformity and continuity of our bookings and revenue.”

Zygo Corporation is a worldwide supplier of optical metrology instruments, precision optics and electro-optical design and manufacturing services serving customers in the semiconductor capital equipment, bio-medical, scientific and industrial markets.

Note: Zygo’s teleconference to discuss the results of the fourth quarter and full year of fiscal 2011 will be held at 5 PM Eastern Time on August 18, 2011 and can be accessed by dialing 800-268-5851. This call is web cast live on Zygo’s web site at www.zygo.com. The call may also be accessed for 30 days following the teleconference.

2


Forward-Looking Statements
All statements other than statements of historical fact included in this news release regarding financial performance, condition and operations and the business strategy, plans, anticipated revenues, bookings, market acceptance, growth rates, market opportunities and objectives of management of the Company for future operations are forward-looking statements. Forward-looking statements provide management’s current expectations or plans for the future operating and financial performance of the Company based upon information currently available and assumptions currently believed to be valid. Forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan(s),” “strategy,” “project” and other words of similar meaning in connection with a discussion of future operating or financial performance. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are fluctuations in capital spending of our customers; fluctuations in revenues to our major customers; manufacturing and supplier risks; risks of booking cancellations, push-outs and de-bookings; dependence on timing and market acceptance of new product development; rapid technological and market change; risks in international operations; risks related to the reorganization of our business; dependence on proprietary technology and key personnel; length of the revenue cycle; environmental regulations; investment portfolio returns; fluctuations in our stock price; the risk that anticipated growth opportunities may be smaller than anticipated or may not be realized; risks related to business acquisitions, including the acquisition of substantially all the assets of ASML US, Inc.’s Richmond, California facility, and integration of the business and employees; the risk related to the Company’s recent changes to senior management; and the risks associated with the recovery from the recent earthquake, tsunami and nuclear disaster in Japan and its impact on our customers, suppliers, and operations. Zygo Corporation undertakes no obligation to publicly update or revise forward-looking statements to reflect events or circumstances after the date of this news release except as required by law. Further information on potential factors that could affect Zygo Corporation’s business is described in our reports on file with the Securities and Exchange Commission, including our Form 10-K for the fiscal year ended June 30, 2010, filed with the Securities and Exchange Commission on September 13, 2010.

Non-GAAP Measures
In this press release, we have presented certain financial measures which have not been determined in accordance with generally accepted accounting principles (GAAP) and are therefore non-GAAP financial measures. Non-GAAP operating profit (loss), as adjusted, non-GAAP net earnings (loss), as adjusted, and non-GAAP net earnings (loss) per share, as adjusted, are operating performance measures defined by the Company and used by the Company’s management to evaluate its operating activities, and a reconciliation of those amounts to reported results is presented below. These non-GAAP financial measures are not intended to replace and should not be considered as alternatives to reported amounts of operating profit (loss), net earnings (loss) or net earnings (loss) per share, which, respectively, are the most directly comparable GAAP financial measures. The Company believes that providing such a reconciliation is useful to users of the financial statements, since it excludes certain significant and unusual charges in the Company’s results, thus enhancing comparability of the Company’s results between periods presented.

3


Zygo Corporation and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)

(Thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
June 30,

 

Twelve Months Ended
June 30,

 

 

 


 


 

 

 

2011

 

2010

 

2011

 

2010

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

42,686

 

$

28,485

 

$

150,126

 

$

101,330

 

Cost of goods sold

 

 

21,854

 

 

16,120

 

 

79,333

 

 

59,361

 

 

 



 



 



 



 

Gross profit

 

 

20,832

 

 

12,365

 

 

70,793

 

 

41,969

 

 

 



 



 



 



 

Selling, general and administrative expenses

 

 

9,819

 

 

6,407

 

 

34,705

 

 

29,520

 

Research, development and engineering expenses

 

 

4,118

 

 

3,195

 

 

14,990

 

 

14,284

 

Impairment of goodwill

 

 

 

 

 

 

 

 

2,003

 

 

 



 



 



 



 

Operating profit (loss)

 

 

6,895

 

 

2,763

 

 

21,098

 

 

(3,838

)

 

 



 



 



 



 

Other income (expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on acquisition

 

 

7

 

 

 

 

1,296

 

 

 

Miscellaneous income (expense), net

 

 

(557

)

 

76

 

 

(486

)

 

138

 

 

 



 



 



 



 

Total other income (expense)

 

 

(550

)

 

76

 

 

810

 

 

138

 

 

 



 



 



 



 

Earnings (loss) from continuing operations before income tax, including noncontrolling interest

 

 

6,345

 

 

2,839

 

 

21,908

 

 

(3,700

)

Income tax benefit (expense)

 

 

158

 

 

1,537

 

 

(1,316

)

 

1,032

 

 

 



 



 



 



 

Net earnings (loss) from continuing operations

 

 

6,503

 

 

4,376

 

 

20,592

 

 

(2,668

)

 

Net earnings (loss) from discontinued operations, net of tax

 

 

 

 

(2

)

 

91

 

 

(2,669

)

 

 



 



 



 



 

Net earnings (loss) including noncontrolling interest

 

 

6,503

 

 

4,374

 

 

20,683

 

 

(5,337

)

Less: Net earnings attributable to noncontrolling interest

 

 

399

 

 

280

 

 

1,604

 

 

957

 

 

 



 



 



 



 

Net earnings (loss) attributable to Zygo Corporation

 

$

6,104

 

$

4,094

 

$

19,079

 

$

(6,294

)

 

 



 



 



 



 

Basic - Earnings (loss) per share attributable to Zygo Corporation

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.34

 

$

0.23

 

$

1.08

 

$

(0.21

)

Discontinued operations

 

 

 

 

 

 

 

 

(0.16

)

 

 



 



 



 



 

Net earnings (loss) per share

 

$

0.34

 

$

0.23

 

$

1.08

 

$

(0.37

)

 

 



 



 



 



 

Diluted - Earnings (loss) per share attributable to Zygo Corporation

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.33

 

$

0.23

 

$

1.05

 

$

(0.21

)

Discontinued operations

 

 

 

 

 

 

 

 

(0.16

)

 

 



 



 



 



 

Net earnings (loss) per share

 

$

0.33

 

$

0.23

 

$

1.05

 

$

(0.37

)

 

 



 



 



 



 

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic shares

 

 

17,756

 

 

17,462

 

 

17,639

 

 

17,183

 

 

 



 



 



 



 

Diluted shares

 

 

18,403

 

 

17,727

 

 

18,140

 

 

17,183

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings (loss) from continuing operations attributable to Zygo Corporation

 

$

6,104

 

$

4,096

 

$

18,988

 

$

(3,625

)

 

 



 



 



 



 

4


Zygo Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)

(Thousands)

 

 

 

 

 

 

 

 

 

 

June 30, 2011

 

June 30, 2010

 

 

 


 


 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

60,039

 

$

46,536

 

Marketable securities

 

 

1,000

 

 

1,000

 

Receivables, net

 

 

31,424

 

 

19,948

 

Inventories

 

 

28,379

 

 

25,220

 

Prepaid expenses and other current assets

 

 

1,745

 

 

1,643

 

Income tax receivable

 

 

 

 

1,050

 

Current assets of discontinued operations

 

 

 

 

17

 

 

 



 



 

Total current assets

 

 

122,587

 

 

95,414

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

980

 

 

922

 

Property, plant and equipment, net

 

 

30,195

 

 

23,029

 

Intangible assets, net

 

 

5,842

 

 

5,387

 

Other assets

 

 

 

 

413

 

 

 



 



 

Total assets

 

$

159,604

 

$

125,165

 

 

 



 



 

 

 

 

 

 

 

 

 

Liabilities and Equity

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

7,120

 

$

8,426

 

Accrued expenses

 

 

19,435

 

 

14,064

 

Income tax payable

 

 

550

 

 

152

 

Current liabilities of discontinued operations

 

 

281

 

 

287

 

 

 



 



 

Total current liabilities

 

 

27,386

 

 

22,929

 

 

 

 

 

 

 

 

 

Other long-term liabilities

 

 

4,131

 

 

1,359

 

Long-term liabilities of discontinued operations

 

 

 

 

281

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stockholders’ equity - Zygo Corporation

 

 

124,720

 

 

98,403

 

Noncontrolling interest

 

 

3,367

 

 

2,193

 

 

 



 



 

Total equity

 

 

128,087

 

 

100,596

 

 

 



 



 

Total liabilities and equity

 

$

159,604

 

$

125,165

 

 

 



 



 

5


Zygo Corporation and Subsidiaries
Reconciliation of Reported Results to Non-GAAP Results
(Unaudited)

(Thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
June 30,

 

Twelve Months Ended
June 30,

 

 

 


 


 

 

 

2011

 

2010

 

2011

 

2010

 

 

 


 


 


 


 

GAAP operating profit (loss), as reported

 

$

6,895

 

$

2,763

 

$

21,098

 

$

(3,838

)

Adjustments to cost of goods sold

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory adjustments *1

 

 

 

 

543

 

 

 

 

543

 

Adjustments to bad debt

 

 

 

 

 

 

 

 

 

 

 

 

 

Bad debt *2

 

 

 

 

(661

)

 

 

 

(661

)

Adjustments to operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill impairment (SG&A)

 

 

 

 

 

 

 

 

2,003

 

Zemetrics acquisition costs (SG&A)

 

 

 

 

 

 

 

 

457

 

Terminated unsolicited merger costs (SG&A)

 

 

 

 

645

 

 

 

 

1,381

 

CEO retirement and search costs (SG&A)

 

 

 

 

 

 

 

 

929

 

Severance charges (SG&A)

 

 

 

 

 

 

 

 

472

 

Severance charges (RD&E)

 

 

 

 

59

 

 

 

 

436

 

Property lease expense (SG&A)

 

 

 

 

 

 

 

 

19

 

 

 



 



 



 



 

Total non-GAAP adjustments to operating expenses

 

 

 

 

586

 

 

 

 

5,579

 

 

 



 



 



 



 

Non-GAAP operating profit, as adjusted

 

 

6,895

 

 

3,349

 

 

21,098

 

 

1,741

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP other income (expense), as reported

 

 

(550

)

 

76

 

 

810

 

 

138

 

Adjustment to other income: Richmond acquisition gain

 

 

(7

)

 

 

 

(1,296

)

 

 

 

 



 



 



 



 

Total non-GAAP other income (expense), as adjusted

 

 

(557

)

 

76

 

 

(486

)

 

138

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP income tax benefit (expense), as reported

 

 

158

 

 

1,537

 

 

(1,316

)

 

1,032

 

Adjustment to income taxes: Valuation allowance *3

 

 

 

 

 

 

(725

)

 

 

 

 



 



 



 



 

Total non-GAAP income tax benefit (expense), as adjusted

 

 

158

 

 

1,537

 

 

(2,041

)

 

1,032

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less: Net earnings attributable to noncontrolling interest, as reported

 

 

399

 

 

280

 

 

1,604

 

 

957

 

 

 



 



 



 



 

Non-GAAP net earnings - continuing operations, as adjusted

 

$

6,097

 

$

4,682

 

$

16,967

 

$

1,954

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP earnings (loss) per diluted share - continuing operations, as reported

 

$

0.33

 

$

0.23

 

$

1.05

 

($

0.21

)

Non-GAAP net earnings diluted per share - continuing operations, as adjusted

 

$

0.33

 

$

0.26

 

$

0.94

 

$

0.11

 

*1 Management has included certain fiscal 2010 inventory adjustments for specific inventory in this reconciliation, because those adjustments are considered unusual due to their nature and size. Inventory adjustments of a nature that occur in the ordinary course have not been included in this reconciliation.

*2 Management has included certain provisions and reversals of provisions in fiscal 2010, primarily related to display customers, as well as the extension of a note receivable to Solvision in this reconciliation as a significant, unusual item. Provisions for doubtful accounts of a nature that occur in the ordinary course have not been included in this reconciliation.

*3 The Company’s reported results for fiscal 2011 and fiscal 2010 include a full valuation allowance on its deferred tax assets. Accordingly, for purposes of computing non-GAAP net earnings (loss), as adjusted, the Company has assumed no tax benefit from deferred tax assets would be recorded in fiscal 2011 and 2010. The adjustment in fiscal 2011 reflects the removal of the tax benefit associated with the change in the valuation allowance due to the effect of the Richmond acquisition.

6